ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc [NASDAQ: ACAD] loss -9.92% on the last trading session, reaching $23.75 price per share at the time. The company report on February 27, 2024 at 4:05 PM that Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating Overview.

Acadia Pharmaceuticals Inc [NASDAQ: ACAD] loss -1.49% or -0.38 points to close at $25.18 with a heavy trading volume of 3529662 shares. The company report on February 13, 2024 at 4:05 PM that Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results